TVTX Market Cap & Key Metrics
Travere Therapeutics, Inc.
$50.49
+$0.89(+1.79%)
43
Overall
40
Value
27
Tech
63
Quality
Market Cap
$4.76B
Volume
1.32M
52W Range
$22.59 - $68.73
Target Price
$75.21
TVTX market cap is $4.76B. This page lists Travere Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
TVTX Key Metrics
- Market cap
- $4.76B
- EPS estimate, current year
- $-0.54
- EPS growth, 3-year
- +59.51%
- Value score
- 40
- Quality score
- 63
- Technical score
- 27
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $490.73M | $233.18M | $145.24M | $109.46M | $227.49M |
| EBITDA | $23.86M | -$264.05M | -$324.53M | -$297.80M | -$184.46M |
| EPS | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TVTX | $50.49 | +1.8% | 1.32M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Travere Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW